Citation: J. Peltola et al., ELEVATED LEVELS OF INTERLEUKIN-6 MAY OCCUR IN CEREBROSPINAL-FLUID FROM PATIENTS WITH RECENT EPILEPTIC SEIZURES, Epilepsy research, 31(2), 1998, pp. 129-133
Citation: J. Peltola et T. Keranen, INTERFERON-BETA IN MULTIPLE-SCLEROSIS - SOME FORM OF COMPROMISE MUST BE ACCEPTED, BMJ. British medical journal, 314(7080), 1997, pp. 602-602
Authors:
KERANEN T
GORDIN A
KOULU M
SCHEININ M
ANTILA S
SUNDBERG S
WIKBERG T
Citation: T. Keranen et al., COMT INHIBITION BY ENTACAPONE DOES NOT AFFECT GROWTH-HORMONE OR PROLACTIN SECRETION IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 103(6), 1996, pp. 729-736
Authors:
KERANEN T
MOBIUS HJ
SCHURREISINGER S
PELTOLA J
ISOJARVI J
MURROS K
SAANO V
ANDERSSON P
MENGE G
EZZET F
SCWABE S
Citation: T. Keranen et al., EFFECT OF OXCARBAZEPINE ON HEPATIC-CLEARANCE OF ANTIPYRINE IN PATIENTS WITH PREVIOUSLY UNTREATED EPILEPSY, Epilepsia, 36, 1995, pp. 161-161
Citation: T. Keranen et J. Riihimaki, SEIZURES AND FAINTS - AN EVALUATION OF 259 PATIENTS WITH TRANSIENT LOSS OF CONSCIOUSNESS, Epilepsia, 36, 1995, pp. 209-209
Authors:
KORPINEN L
PIETILA T
PELTOLA J
NISSILA M
KERANEN T
TUOVINEN T
FALCK B
PETRANEK ES
FREY H
Citation: L. Korpinen et al., EVALUATION OF EPILEPSY EXPERT - A DECISION-SUPPORT SYSTEM, Computer methods and programs in biomedicine, 45(3), 1994, pp. 223-231
Authors:
KERANEN T
GORDIN A
KARLSSON M
KORPELA K
PENTIKAINEN PJ
RITA H
SCHULTZ E
SEPPALA L
WIKBERG T
Citation: T. Keranen et al., INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 151-157
Authors:
SUNDBERG S
SCHEININ M
ILLI A
AKKILA J
GORDIN A
KERANEN T
Citation: S. Sundberg et al., THE EFFECTS OF THE COMT INHIBITOR ENTACAPONE ON HEMODYNAMICS AND PERIPHERAL CATECHOLAMINE METABOLISM DURING EXERCISE, British journal of clinical pharmacology, 36(5), 1993, pp. 451-456
Authors:
MYLLYLA VV
SOTANIEMI KA
ILLI A
SUOMINEN K
KERANEN T
Citation: Vv. Myllyla et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS OF LEVODOPA AND ON CARDIOVASCULAR-RESPONSES IN PATIENTS WITH PARKINSONS-DISEASE, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 419-423